pyruvic acid has been researched along with cb-839 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baran, N; Bhattacharya, PK; Cai, T; Dutta, P; Konopleva, M; Lee, J; Lujan, JV; Millward, SW; Piwnica-Worms, D; Shanmugavelandy, SS; Wood, CG; Zacharias, NM | 1 |
| Baguley, BC; Dechaume, AL; Katt, WP; Leung, EY; Murray, PM; Singleton, DC | 1 |
2 other study(ies) available for pyruvic acid and cb-839
| Article | Year |
|---|---|
Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia.
Topics: Animals; Benzeneacetamides; Cell Line, Tumor; Cell Proliferation; Cell Survival; HL-60 Cells; Humans; Lactic Acid; Leukemia, Myeloid, Acute; Magnetic Resonance Spectroscopy; Male; Mice; Pyruvic Acid; Thiadiazoles; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.
Topics: Benzeneacetamides; Cell Proliferation; Drug Resistance, Neoplasm; Female; Glutaminase; Glutamine; Humans; Pyruvic Acid; Thiadiazoles; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Tumor Microenvironment | 2020 |